Gastrodin ameliorates microvascular reperfusion injury-induced pyroptosis by regulating the NLRP3/caspase-1 pathway

Area of Science:

• Cardiovascular Biology
• Inflammation Research
• Molecular Medicine

Background:

• Myocardial reperfusion injury involves inflammation and microvascular dysfunction.
• The NLRP3 inflammasome (NACHT, LRR, and PYD domains-containing protein 3) mediates inflammatory responses.
• Molecular mechanisms linking reperfusion to inflammation are not fully understood.

Purpose of the Study:

• To investigate the role of the NLRP3 inflammasome in myocardial reperfusion-induced microvascular injury.
• To evaluate the therapeutic potential of Gastrodin in mitigating this injury.

Main Methods:

• Assessed NLRP3 inflammasome activation and pyroptosis in cardiac microvascular endothelial cells and a myocardial ischemia/reperfusion (I/R) animal model.
• Treated cells and animals with Gastrodin, a component of Gastrodia elata.
• Measured IL-1β production, infarct size, inflammatory cell infiltration, and capillary formation.

Main Results:

• NLRP3 inflammasome activation and pyroptosis were observed in cardiac microvascular endothelial cells and the I/R model.
• Gastrodin inhibited NLRP3/caspase-1 pathway activation, blocking pyroptosis and reducing IL-1β production.
• Gastrodin treatment attenuated infarct size, decreased inflammatory cell infiltration, and promoted capillary formation.

Conclusions:

• The NLRP3 inflammasome plays a critical role in myocardial reperfusion-induced microvascular injury.
• Gastrodin effectively inhibits pyroptosis via the NLRP3/caspase-1 pathway.
• Gastrodin demonstrates therapeutic potential for treating NLRP3-associated inflammatory diseases and myocardial reperfusion injury.